• 1.

    Zeng Z, Zhan J, Chen L, Chen H, Cheng S, 2021. Global, regional, and national dengue burden from 1990 to 2017: a systematic analysis based on the global burden of disease study 2017. EClinicalMedicine 32: 100712.

    • Search Google Scholar
    • Export Citation
  • 2.

    Bhat S et al., 2013. The global distribution and burden of dengue. Nature 496: 504507.

  • 3.

    WHO , 2017. Informing Vaccination Programs: A Guide to the Design and Conduct of Dengue Serosurveys. Geneva, Switzerland: World Health Organization. Available at: https://www.who.int/immunization/research/development/Dengue_Serosurveys_020617.pdf?ua=1. Accessed June 14, 2020.

  • 4.

    Rodríguez-Barraquer I, Solomon SS, Kuganantham P, Srikrishnan AK, Vasudevan CK, Iqbal SH, Balakrishnan P, Solomon S, Mehta SH, Cummings DA, 2015. The hidden burden of dengue and chikungunya in Chennai, India. PLoS Negl Trop Dis 9: e0003906.

    • Search Google Scholar
    • Export Citation
  • 5.

    Mishra AC, Arankalle VA, Gadhave SA, Mahadik PH, Shrivastava S, Bhutkar M, Vaidya VM, 2018. Stratified sero-prevalence revealed overall high disease burden of dengue but suboptimal immunity in younger age groups in Pune, India. PLoS Negl Trop Dis 12: e0006657.

    • Search Google Scholar
    • Export Citation
  • 6.

    World Health Organization , 2009. Dengue Guidelines for Diagnosis, Treatment, Prevention and Control. Available at: https://apps.who.int/iris/bitstream/handle/10665/44188/9789241547871_eng.pdf?sequence=1&isAllowed=y. Accessed April 5, 2021.

  • 7.

    World Health Organization , 2012. Global Strategy for Dengue Prevention and Control 2012–2020. Available at: https://apps.who.int/iris/bitstream/handle/10665/75303/9789241504034_eng.pdf;jsessionid=8E2D7282CF8EF668A3E43A4E24EAF680?sequence=1. Accessed April 5, 2021.

  • 8.

    Murhekar MV et al., 2019. Burden of dengue infection in India, 2017: a cross-sectional population based serosurvey. Lancet Glob Health 7: e1065e1073.

    • Search Google Scholar
    • Export Citation
  • 9.

    Abbott, 2020. Panbio Dengue IgG Capture ELISA Available at: https://www.alere.com/en/home/product-details/panbio-dengue-igg-capture-elisa.html. Accessed June 13, 2020.

  • 10.

    Gubler DJ, 2011. Dengue, urbanization and globalization: the unholy trinity of the 21(st) century. Trop Med Health 39: 311.

  • 11.

    Ganeshkumar P, Murhekar MV, Poornima V, Saravanakumar V, Sukumaran K, Anandaselvasankar A, John D, Mehendale SM, 2018. Dengue infection in India: a systematic review and meta-analysis. PLoS Negl Trop Dis 12: e0006618.

    • Search Google Scholar
    • Export Citation
 
 
 
 

 

 
 
 

 

 

 

 

 

 

Seroprevalence of Dengue Infection Using IgG Capture ELISA in India, 2017–2018

View More View Less
  • 1 Indian Council of Medical Research (ICMR)-National Institute of Epidemiology, Chennai, India;
  • | 2 ICMR-Regional Medical Research Centre, Northeast Region, Dibrugarh, India;
  • | 3 Science Health Allied Research Education India, Hyderabad, India;
  • | 4 ICMR-National Institute of Research in Tribal Health, Jabalpur, India;
  • | 5 ICMR-Regional Medical Research Centre, Bhubaneswar, India;
  • | 6 ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India;
  • | 7 King George’s Medical University, Lucknow, India;
  • | 8 ICMR, National Institute for Implementation Research on Non-Communicable Diseases, Jodhpur, India;
  • | 9 ICMR-National Institute of Traditional Medicine, Belagavi, India;
  • | 10 Postgraduate Institute of Medical Education and Research, Chandigarh, India;
  • | 11 ICMR-National Institute of Malaria Research, New Delhi, India;
  • | 12 ICMR-National Institute of Virology, Pune, India;
  • | 13 ICMR-Rajendra Memorial Research Institute of Medical Sciences, Patna, India

ABSTRACT.

We conducted a nationally representative population-based survey in 60 districts from 15 Indian states covering all five geographic regions during 2017–2018 to estimate the age specific seroprevalence of dengue. Of the 12,300 sera collected, 4,955 were positive for IgG antibodies against dengue virus using IgG Indirect ELISA indicating past dengue infection. We tested 4,948 sera (seven had inadequate volume) positive for IgG antibodies on indirect ELISA using anti-dengue IgG capture ELISA to estimate the proportion of dengue infections with high antibody titers, suggestive of acute or recent secondary infection. Of the 4,948 sera tested, 529 (10.7%; 95% CI: 9.4–12.1) were seropositive on IgG capture ELISA. The proportions of dengue infections with high titers were 1.1% in the northeastern, 1.5% in the eastern, 6.2% in the western, 12.2% in the southern, and 16.7% in the northern region. The distribution of dengue infections varied across geographic regions, with a higher proportion of infections with high antibody titer in the northern and southern regions of India. The study findings could be useful for planning facilities for clinical management of dengue infections.

    • Supplemental Materials (DOCX 104 KB)

Author Notes

*Address correspondence to Manoj Murhekar, ICMR-National Institute of Epidemiology, R127, TNHB, Ayapakkam, Chennai-600077, India. E-mail: mmurhekar@nieicmr.org.in

These authors contributed equally to this work.

Financial support: This study was funded by Indian Council of Medical Research, New Delhi

Authors’ addresses: Muthusamy Santhosh Kumar, P. Kamaraj, C. P. Girish Kumar, R. Sabarinathan, V. Saravana Kumar, T. Karunakaran, Annamma Jose, and Manoj Murhekar, ICMR-National Institute of Epidemiology, Chennai, India, E-mails: drsanthosmph09@gmail.com, pkrajreddy@gmail.com, girishmicro@gmail.com, sabari@nieicmr.org.in, saravanan.biostat1985@gmail.com, thiyakaruna@gmail.com, and aanjose.9@gmail.com. Siraj Ahmed Khan, ICMR-Regional Medical Research Centre, Northeast Region, Dibrugarh, India, E-mail: sirajkhanicmr@gmail.com. Ramesh Reddy Allam, Science Health Allied Research Education India, Hyderabad, India, E-mail: rameshallam@sharefoundations.org. Pradip V. Barde, ICMR-National Institute of Research in Tribal Health, Jabalpur, India, E-mail: pradip_barde@hotmail.com. Bhagirathi Dwibedi, ICMR-Regional Medical Research Centre, Bhubaneswar, India, E-mail: bhagirathidwibedi@yahoo.com. Suman Kanungo, Provash Sadhukhan, and Shanta Dutta, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India, E-mails: sumankanungo@gmail.com, provash2000@gmail.com, and shanta1232001@gmail.com. Uday Mohan, King George’s Medical University, Lucknow, India, E-mail: drudaymohan@yahoo.co.in. Suman Sundar Mohanty and G. S. Toteja, ICMR, National Institute for Implementation Research on Non-Communicable Diseases, Jodhpur, India, E-mails: ssnimr@gmail.com and gstoteja@gmail.com. Subarna Roy, ICMR-National Institute of Traditional Medicine, Belagavi, India, E-mail: drsubarnaroy@gmail.com. Vivek Sagar, Postgraduate Institute of Medical Education and Research, Chandigarh, India, E-mail: vivekgenetics@gmail.com. Deepali Savargaonkar, ICMR-National Institute of Malaria Research, New Delhi, India, E-mail: dr.deepali27@gmail.com. Babasaheb V. Tandale, ICMR-National Institute of Virology, Pune, India, E-mail: drtandale@gmail.com. Roshan Kamal Topno, ICMR-Rajendra Memorial Research Institute of Medical Sciences, Patna, India, E-mail: roshanktopno@yahoo.co.in.

Save